Spring is not too much of a stretch to get herd immunity for the U.S., says Bernstein senior analyst
Ronny Gal, Bernstein senior analyst, joins 'Closing Bell' to discuss the timeline for when the U.S. could reach herd immunity on Covid-19 once there is a readily available vaccine. He also talks about the vaccine's impact on markets.
Видео Spring is not too much of a stretch to get herd immunity for the U.S., says Bernstein senior analyst канала CNBC Television
Видео Spring is not too much of a stretch to get herd immunity for the U.S., says Bernstein senior analyst канала CNBC Television
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
Cramer says FAANG stocks aren't going away any time soon amid market rotation
Brace for bad news because vaccine news is baked into the market: BTIG's Emanuel
Salesforce, Slack deal expected to be announced Dec. 1: Sources
Congress to continue stimulus talks as the deadline approaches
Here's why Guggenheim is set to join the cryptocurrency craze
S&P Global to buy IHS Markit: What it means for the ETF industry and beyond
Salesforce's deal for Slack could be announced tomorrow
Chance of OPEC deal is overwhelming: Citi's Ed Morse
Kara Swisher on DoorDash and Airbnb going public: Both companies represent the 'accelerated future'
GM will no longer take an equity stake in Nikola
Loss of GM costs Nikola huge endorsement: WSJ's Tim Higgins
S&P Global to buy IHS Markit in biggest deal of 2020
How Autonomous Robots Are Changing Construction
Apex Financial's Lee Baker on the market's record month
KKM's Jeff Kilburg talks about the market's record November run
Analyst on the retail names he's watching this holiday season
Cramer's lightning round: I think Peloton's too hard
S&P Global CEO says recurring revenue to make up bulk of rating agency's business
Vaccine's ability to slow spread needs to be demonstrated: Dr. Scott Gottlieb
Smart-glass startup View CEO says its business is poised for growth after it goes public via SPAC me